This trust is not misplaced, but it is not automatic either. It must be earned through the investigator's vigilance, competence, and commitment to both treating adverse events and reporting them. These are the twin pillars of Section 2.7: medical care and safety reporting.

I have spent decades observing how sites handle adverse events, and I can tell you that the difference between excellent and mediocre safety management often comes down to something simple. Does the site treat adverse events as inconvenient interruptions to be documented and forgotten, or as clinical obligations that demand genuine medical attention and meticulous reporting? The former approach technically complies with requirements. The latter actually protects participants.

Section 2.7 of ICH E6(R3) Annex 1 codifies what excellent sites already know: participants deserve both competent medical care when adverse events occur and confidence that their experience will be captured accurately enough to protect future participants.

This trust is not misplaced, but it is not automatic either. It must be earned through the investigator's vigilance, competence, and commitment to both treating adverse events and reporting them. These are the twin pillars of Section 2.7: medical care and safety reporting.

I have spent decades observing how sites handle adverse events, and I can tell you that the difference between excellent and mediocre safety management often comes down to something simple. Does the site treat adverse events as inconvenient interruptions to be documented and forgotten, or as clinical obligations that demand genuine medical attention and meticulous reporting? The former approach technically complies with requirements. The latter actually protects participants.

Section 2.7 of ICH E6(R3) Annex 1 codifies what excellent sites already know: participants deserve both competent medical care when adverse events occur and confidence that their experience will be captured accurately enough to protect future participants.